United States of America v. Gold Star Distribution, Inc. and Bassam Abu Samrah

Background

The United States brought the action on behalf of the Food and Drug Administration against Gold Star Distribution, Inc. and its owner, Bassam Abu Samrah. The complaint alleged repeated violations of the Federal Food, Drug, and Cosmetic Act and sought an injunction against further violations.

Gold Star operates a warehouse that receives, holds, and distributes food, drugs, devices, cosmetics, and other products. The opinion states that inspections by the Food and Drug Administration and the Minnesota Department of Agriculture between 2013 and 2025 found live and dead rodents, gnaw marks, damaged packages, rodent excrement, possible rodent nests, urine stains, birds, worms, other pests, and animal filth.

The United States filed the action on September 11, 2026. The parties then reached a settlement, and on September 14, 2026, they filed a consent motion asking the court to approve a proposed consent decree.

Proposed Consent Decree

Among other provisions, the proposed decree would permanently enjoin the defendants from receiving, holding for sale, or distributing Food and Drug Administration-regulated products until specified conditions were met. It would require the defendants to destroy all such products in their custody, possession, or control; adopt procedures to prevent future violations, including retaining an independent auditor; and pay liquidated damages for each day that violations continued.

Court’s Analysis

The court explained that it may review and approve a consent decree when the parties jointly seek one and the decree would protect federal interests. The court applied three standards: procedural fairness, reasonableness, and legal adequacy.

For procedural fairness, the court considered whether negotiations were conducted in good faith and at arm’s length. It found no indication that the proposed decree resulted from anything other than fair play. The court noted that the parties were represented by counsel and had communicated about the alleged insanitary conditions for years.

For reasonableness, the court asked whether the decree arose from and resolved a dispute within the court’s jurisdiction, fell within the scope of the complaint, and advanced the goals of the Federal Food, Drug, and Cosmetic Act. The court concluded that the alleged violations of 21 U.S.C. § 331(k) presented a federal question and that the decree’s requirements to improve sanitation and stop distribution until conditions improved were designed to prevent future violations.

For legal adequacy, the court considered whether the decree reflected governing law. It concluded that the decree was consistent with the Act because it required the defendants to refrain from future violations and adopt reforms intended to ensure compliance.

Disposition

The court held that the proposed consent decree was procedurally fair, reasonable, and consistent with governing law. It granted the motion for entry of the consent decree and ordered that judgment be entered accordingly. The opinion approved the settlement; it did not independently decide whether the defendants committed the alleged violations after a trial.